Relora Helps Treat Stress, Sleeplessness

SALINAS, Calif.Next Pharmaceuticals announced the results of an open label study on Relora®, which included 1,291 participants who suffered from stress, sleeplessness and/or stress-related eating. The study was conducted at the LaValle Metabolic Institute in Cincinnati. Ninety-one percent of the subjects reported Relora, a patented blend of Magnolia bark extract and a proprietary blend of Pellodendron bark extract, helped them relax, while 90 percent said it helped them have a restful sleep. Eighty-six percent reported Relora helped prevent stress-related eating.

This study demonstrates Relora can be a successful adjunct for individuals who experience stress and anxiety, or who turn to food when dealing with tension, said Charles Kosmont, CEO of Next Pharmaceuticals. There are many methods to managing stress, and this clinical study supports the fact that Relora is a natural, safe and effective approach with no toxic side effects.

For more information, visit www.NextPharmaceuticals.com or Booth #14054 at SupplySide West.